Monte Rosa Therapeutics' stock traded on the Nasdaq exchange, and the company disclosed transactions with the SEC, including an insider sale on June 24th.
4 reports, 2 independent
Updated Jul 3
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Monte Rosa Therapeutics' stock traded on the Nasdaq exchange, and the company disclosed transactions with the SEC, including an insider sale on June 24th.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Monte Rosa Therapeutics officially listed its shares on the Nasdaq exchange.1 source
- Monte Rosa Therapeutics filed transactions via SEC Form 4 on June 29, involving Chief Medical Officer Filip Janku.Sub-event
Monte Rosa Therapeutics stock traded on Nasdaq; company filed with SEC regarding transactions and insider sales.1 source
Keep exploring
The entities involved
-
Monte Rosa Therapeutics
biotechnology company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
SEC
Slovak company
Related events
- Twin Vee PowerCats filed required disclosures with the SEC and its stock began trading on the Nasdaq exchange.
- A stock is reported to be traded on the Nasdaq exchange.
- InnovAge Holding Corp. stock is traded on Nasdaq, and large shareholders must disclose transactions to the SEC.
- City Holding Co. traded on the Nasdaq stock exchange today.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.